Total Payments
$2,959
2024 Payments
$715.02
Companies
23
Transactions
153
Medicare Patients
12,667
Medicare Billing
$792,460
Payment Breakdown by Category
Food & Beverage$2,684 (90.7%)
Education$275.24 (9.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,684 | 149 | 90.7% |
| Education | $275.24 | 4 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $484.12 | 20 | $0 (2024) |
| UCB, Inc. | $415.74 | 21 | $0 (2024) |
| Lilly USA, LLC | $363.51 | 19 | $0 (2024) |
| ABBVIE INC. | $227.51 | 14 | $0 (2024) |
| Amgen Inc. | $219.05 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $198.14 | 9 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $183.49 | 12 | $0 (2024) |
| Celgene Corporation | $157.46 | 12 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $98.11 | 5 | $0 (2021) |
| Galderma Laboratories, L.P. | $92.45 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $715.02 | 34 | UCB, Inc. ($160.22) |
| 2023 | $519.84 | 24 | Janssen Biotech, Inc. ($139.57) |
| 2022 | $314.03 | 19 | UCB, Inc. ($65.09) |
| 2021 | $514.55 | 27 | Regeneron Healthcare Solutions, Inc. ($106.81) |
| 2020 | $130.33 | 8 | Lilly USA, LLC ($51.98) |
| 2019 | $296.54 | 11 | Janssen Biotech, Inc. ($79.99) |
| 2018 | $171.00 | 8 | Janssen Scientific Affairs, LLC ($69.41) |
| 2017 | $298.03 | 22 | Celgene Corporation ($157.46) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/04/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: DERMATOLOGY | ||||||
| 08/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Immunology | ||||||
| 07/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: Immunology | ||||||
| 07/30/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Immunology | ||||||
| 07/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Dermatology | ||||||
| 07/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: IMMUNOLOGY | ||||||
| 07/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Immunology | ||||||
| 07/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.08 | General |
| Category: Immunology | ||||||
| 06/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.18 | General |
| Category: Immunology | ||||||
| 06/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: IMMUNOLOGY | ||||||
| 06/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Dermatology | ||||||
| 05/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.45 | General |
| Category: Immunology | ||||||
| 05/28/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $7.29 | General |
| Category: Immunology | ||||||
| 05/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.52 | General |
| Category: Dermatology | ||||||
| 05/07/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Immunology | ||||||
| 05/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: Immunology | ||||||
| 04/30/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 2,723 | 5,689 | $763,625 | $158,716 |
| 2022 | 14 | 3,269 | 6,878 | $963,175 | $203,264 |
| 2021 | 15 | 3,652 | 8,077 | $1.1M | $237,521 |
| 2020 | 15 | 3,023 | 6,292 | $861,215 | $192,960 |
Total Patients
12,667
Total Services
26,936
Medicare Billing
$792,460
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 887 | 1,154 | $293,880 | $59,472 | 20.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 592 | 754 | $142,051 | $26,439 | 18.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 218 | 243 | $77,258 | $16,631 | 21.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 198 | 223 | $63,418 | $14,224 | 22.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 96 | 134 | $63,328 | $14,137 | 22.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 484 | 2,866 | $54,002 | $12,792 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 56 | $20,218 | $4,476 | 22.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 80 | 95 | $15,079 | $3,187 | 21.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $14,764 | $3,000 | 20.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 28 | 53 | $7,477 | $1,994 | 26.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 17 | 18 | $6,328 | $1,374 | 21.7% |
| 69100 | Biopsy of ear | Office | 2023 | 17 | 17 | $4,606 | $829.99 | 18.0% |
| Q0112 | All potassium hydroxide (koh) preparations | Office | 2023 | 26 | 29 | $1,218 | $159.89 | 13.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 982 | 1,371 | $354,529 | $75,301 | 21.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 715 | 946 | $177,956 | $33,075 | 18.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 255 | 302 | $96,653 | $22,488 | 23.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 290 | 333 | $97,212 | $19,592 | 20.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 103 | 169 | $79,719 | $17,868 | 22.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 548 | 3,326 | $61,525 | $15,132 | 24.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 109 | 109 | $34,614 | $6,541 | 18.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 104 | 129 | $20,536 | $4,408 | 21.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 63 | 82 | $12,134 | $2,845 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 33 | $12,127 | $2,483 | 20.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 15 | 17 | $6,211 | $1,536 | 24.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 25 | 25 | $5,150 | $970.67 | 18.8% |
About Dr. Jennifer Palmer, M.D
Dr. Jennifer Palmer, M.D is a Dermatology healthcare provider based in Pella, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801893862.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Palmer, M.D has received a total of $2,959 in payments from pharmaceutical and medical device companies, with $715.02 received in 2024. These payments were reported across 153 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,684).
As a Medicare-enrolled provider, Palmer has provided services to 12,667 Medicare beneficiaries, totaling 26,936 services with total Medicare billing of $792,460. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Pella, IA
- Active Since 07/06/2005
- Last Updated 09/14/2011
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1801893862
Products in Payments
- TREMFYA (Drug) $333.43
- TALTZ (Drug) $330.14
- Otezla (Drug) $278.32
- Cimzia (Drug) $255.52
- DUPIXENT (Biological) $208.21
- Tremfya (Drug) $161.99
- Bimzelx (Biological) $160.22
- ILUMYA (Biological) $102.10
- COSENTYX (Biological) $98.11
- Humira (Biological) $69.69
- RINVOQ (Biological) $66.02
- SKYRIZI (Biological) $65.15
- EUCRISA (Drug) $64.35
- REMICADE (Biological) $58.11
- OPZELURA (Drug) $53.68
- Enbrel (Biological) $46.87
- Sotyktu (Drug) $45.76
- Winlevi (Drug) $43.18
- LIBTAYO (Biological) $38.91
- Ilumya (Biological) $38.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.